Under construction – not a live service
Sign in
Taking people in ThailandNo phase

Studies people in the early stage of HIV infection and their sexual contacts

Describes people recently infected with HIV, including their health and their sexual contacts.

Plain-language title generated from the registry record
Registry title: Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population

Key facts

Where
Bangkok, ThailandSee the site

Where in Thailand

  • Institute of HIV Research and Innovation (IHRI)Bangkok, ThailandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
SEARCH Research Foundation
Trial code
NCT00796146
Record updated
27 April 2026
Original description
To describe clinical, immunological, and virological characteristics of persons with acute HIV infectionRead full original descriptionShow less

To describe clinical, immunological, and virological characteristics of persons with acute HIV infection

1. To describe demographics and behavioral risk factors for those identified with acute HIV infection 2. To describe neurocognitive function and neuroimaging findings in acute HIV infection as well as describe immune response, HIV-1 genotypes and sequences in the cerebrospinal fluid. 3. To describe the number and characteristics of sexual contacts 4. To describe the willingness of acute HIV-infected subjects to allow the tracking of their sexual contacts for voluntary HIV counseling and testing (VCT) 5. To describe immune response, HIV-1 genotypes and sequences in the genital compartment 6. To describe T cell depletion in the gut mucosa in acute HIV infection and describe the changes in gut T cell during follow up 7. To archive samples for future investigations including determination of viral evolution, and cell-mediated and humoral immune responses in peripheral blood and mucosal compartments

Inclusion: Age >18 years old; Have protocol-defined acute HIV-1 infection (Tested 4th generation HIV EIA negative and NAT positive or tested 4th generation HIV EIA positive, negative by less sensitive EIA and NAT positive); Understand the study and sign informed consent form. Persons who cannot read will have the consent form read to them by a study staff and they can give informed consent by using thumb print; Availability for follow-up for the planned study duration.

Exclusion: Persons who have a history of a medical or psychiatric disorder by investigator's interview and physical examination according to standard practices, that in the judgment of the investigator(s), would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent; Female participants who are pregnant at the time of screening.

ClinicalTrials.gov NCT00796146